vs
奥驰亚(MO)与摩森康胜饮品公司(TAP)财务数据对比。点击上方公司名可切换其他公司
奥驰亚的季度营收约是摩森康胜饮品公司的1.9倍($5.8B vs $3.1B)。奥驰亚净利率更高(19.1% vs 7.6%,领先11.5%)。奥驰亚同比增速更快(-2.1% vs -3.6%)。奥驰亚自由现金流更多($3.2B vs $357.8M)。过去两年奥驰亚的营收复合增速更高(2.4% vs 1.2%)
奥驰亚集团是美国头部烟草企业,通过旗下子公司生产销售可燃烟草与口服类烟草相关产品,核心品牌包括万宝路香烟、Black & Mild雪茄及烟斗烟、哥本哈根、斯库尔等湿无烟烟草,以及on!口服尼古丁袋,产品主要供应批发商、分销商及大型零售客户。
摩森康胜饮品公司是一家美加合资的跨国饮料酿造企业,旗下拥有多款知名酒精及非酒精饮品产品线,业务覆盖全球多个国家和地区,目前在伊利诺伊州芝加哥与魁北克省蒙特利尔设有双总部。
MO vs TAP — 直观对比
营收规模更大
MO
是对方的1.9倍
$3.1B
营收增速更快
MO
高出1.5%
-3.6%
净利率更高
MO
高出11.5%
7.6%
自由现金流更多
MO
多$2.8B
$357.8M
两年增速更快
MO
近两年复合增速
1.2%
损益表 — Q4 2025 vs Q4 2025
| 指标 | ||
|---|---|---|
| 营收 | $5.8B | $3.1B |
| 净利润 | $1.1B | $238.3M |
| 毛利率 | 62.1% | 31.0% |
| 营业利润率 | 28.2% | 10.4% |
| 净利率 | 19.1% | 7.6% |
| 营收同比 | -2.1% | -3.6% |
| 净利润同比 | -63.2% | -17.2% |
| 每股收益(稀释后) | $0.67 | $1.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
MO
TAP
| Q4 25 | $5.8B | $3.1B | ||
| Q3 25 | $6.1B | $3.5B | ||
| Q2 25 | $6.1B | $3.7B | ||
| Q1 25 | $5.3B | $2.7B | ||
| Q4 24 | $6.0B | $3.2B | ||
| Q3 24 | $6.3B | $3.6B | ||
| Q2 24 | $6.2B | $3.8B | ||
| Q1 24 | $5.6B | $3.0B |
净利润
MO
TAP
| Q4 25 | $1.1B | $238.3M | ||
| Q3 25 | $2.4B | $-2.9B | ||
| Q2 25 | $2.4B | $428.7M | ||
| Q1 25 | $1.1B | $121.0M | ||
| Q4 24 | $3.0B | $287.8M | ||
| Q3 24 | $2.3B | $199.8M | ||
| Q2 24 | $3.8B | $427.0M | ||
| Q1 24 | $2.1B | $207.8M |
毛利率
MO
TAP
| Q4 25 | 62.1% | 31.0% | ||
| Q3 25 | 62.8% | 33.7% | ||
| Q2 25 | 63.1% | 34.3% | ||
| Q1 25 | 61.8% | 31.6% | ||
| Q4 24 | 60.3% | 32.0% | ||
| Q3 24 | 60.8% | 33.4% | ||
| Q2 24 | 59.2% | 34.6% | ||
| Q1 24 | 58.8% | 31.6% |
营业利润率
MO
TAP
| Q4 25 | 28.2% | 10.4% | ||
| Q3 25 | 53.2% | -98.5% | ||
| Q2 25 | 52.9% | 15.6% | ||
| Q1 25 | 34.0% | 6.9% | ||
| Q4 24 | 48.2% | 12.0% | ||
| Q3 24 | 50.4% | 12.5% | ||
| Q2 24 | 40.8% | 15.6% | ||
| Q1 24 | 48.0% | 10.3% |
净利率
MO
TAP
| Q4 25 | 19.1% | 7.6% | ||
| Q3 25 | 39.1% | -84.0% | ||
| Q2 25 | 39.0% | 11.5% | ||
| Q1 25 | 20.5% | 4.5% | ||
| Q4 24 | 50.9% | 8.9% | ||
| Q3 24 | 36.6% | 5.5% | ||
| Q2 24 | 61.2% | 11.1% | ||
| Q1 24 | 38.2% | 6.8% |
每股收益(稀释后)
MO
TAP
| Q4 25 | $0.67 | $1.32 | ||
| Q3 25 | $1.41 | $-14.79 | ||
| Q2 25 | $1.41 | $2.13 | ||
| Q1 25 | $0.63 | $0.59 | ||
| Q4 24 | $1.78 | $1.39 | ||
| Q3 24 | $1.34 | $0.96 | ||
| Q2 24 | $2.21 | $2.03 | ||
| Q1 24 | $1.21 | $0.97 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $4.5B | $896.5M |
| 总债务越低越好 | $25.7B | $6.3B |
| 股东权益账面价值 | $-3.5B | $10.2B |
| 总资产 | $35.0B | $22.7B |
| 负债/权益比越低杠杆越低 | — | 0.61× |
8季度趋势,按日历期对齐
现金及短期投资
MO
TAP
| Q4 25 | $4.5B | $896.5M | ||
| Q3 25 | $3.5B | $950.2M | ||
| Q2 25 | $1.3B | $613.8M | ||
| Q1 25 | $4.7B | $412.7M | ||
| Q4 24 | $3.1B | $969.3M | ||
| Q3 24 | $1.9B | $1.0B | ||
| Q2 24 | $1.8B | $1.6B | ||
| Q1 24 | $3.6B | $458.4M |
总债务
MO
TAP
| Q4 25 | $25.7B | $6.3B | ||
| Q3 25 | $25.7B | $6.3B | ||
| Q2 25 | $24.7B | $6.3B | ||
| Q1 25 | $26.1B | $6.2B | ||
| Q4 24 | $24.9B | $6.1B | ||
| Q3 24 | $25.2B | $6.2B | ||
| Q2 24 | $25.0B | $7.0B | ||
| Q1 24 | $25.0B | $6.2B |
股东权益
MO
TAP
| Q4 25 | $-3.5B | $10.2B | ||
| Q3 25 | $-2.6B | $10.3B | ||
| Q2 25 | $-3.3B | $13.4B | ||
| Q1 25 | $-3.5B | $13.1B | ||
| Q4 24 | $-2.2B | $13.1B | ||
| Q3 24 | $-3.5B | $13.3B | ||
| Q2 24 | $-3.0B | $13.2B | ||
| Q1 24 | $-5.1B | $13.1B |
总资产
MO
TAP
| Q4 25 | $35.0B | $22.7B | ||
| Q3 25 | $35.0B | $22.9B | ||
| Q2 25 | $32.3B | $26.8B | ||
| Q1 25 | $35.8B | $25.9B | ||
| Q4 24 | $35.2B | $26.1B | ||
| Q3 24 | $34.2B | $26.6B | ||
| Q2 24 | $34.4B | $27.4B | ||
| Q1 24 | $36.5B | $26.1B |
负债/权益比
MO
TAP
| Q4 25 | — | 0.61× | ||
| Q3 25 | — | 0.61× | ||
| Q2 25 | — | 0.47× | ||
| Q1 25 | — | 0.47× | ||
| Q4 24 | — | 0.47× | ||
| Q3 24 | — | 0.47× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.47× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $3.3B | $540.7M |
| 自由现金流经营现金流 - 资本支出 | $3.2B | $357.8M |
| 自由现金流率自由现金流/营收 | 54.4% | 11.4% |
| 资本支出强度资本支出/营收 | 1.6% | 5.9% |
| 现金转化率经营现金流/净利润 | 2.93× | 2.27× |
| 过去12个月自由现金流最近4个季度 | $9.1B | $1.1B |
8季度趋势,按日历期对齐
经营现金流
MO
TAP
| Q4 25 | $3.3B | $540.7M | ||
| Q3 25 | $3.1B | $616.1M | ||
| Q2 25 | $205.0M | $718.3M | ||
| Q1 25 | $2.7B | $-90.7M | ||
| Q4 24 | $3.3B | $494.5M | ||
| Q3 24 | $2.6B | $521.2M | ||
| Q2 24 | $-75.0M | $869.2M | ||
| Q1 24 | $2.9B | $25.4M |
自由现金流
MO
TAP
| Q4 25 | $3.2B | $357.8M | ||
| Q3 25 | $3.0B | $483.0M | ||
| Q2 25 | $173.0M | $555.0M | ||
| Q1 25 | $2.7B | $-328.0M | ||
| Q4 24 | $3.3B | $383.4M | ||
| Q3 24 | $2.6B | $350.4M | ||
| Q2 24 | $-104.0M | $691.7M | ||
| Q1 24 | $2.8B | $-189.3M |
自由现金流率
MO
TAP
| Q4 25 | 54.4% | 11.4% | ||
| Q3 25 | 50.1% | 13.9% | ||
| Q2 25 | 2.8% | 14.8% | ||
| Q1 25 | 51.0% | -12.2% | ||
| Q4 24 | 55.1% | 11.8% | ||
| Q3 24 | 41.2% | 9.7% | ||
| Q2 24 | -1.7% | 18.0% | ||
| Q1 24 | 51.0% | -6.2% |
资本支出强度
MO
TAP
| Q4 25 | 1.6% | 5.9% | ||
| Q3 25 | 0.9% | 3.8% | ||
| Q2 25 | 0.5% | 4.4% | ||
| Q1 25 | 0.7% | 8.8% | ||
| Q4 24 | 0.8% | 3.4% | ||
| Q3 24 | 0.5% | 4.7% | ||
| Q2 24 | 0.5% | 4.6% | ||
| Q1 24 | 0.6% | 7.0% |
现金转化率
MO
TAP
| Q4 25 | 2.93× | 2.27× | ||
| Q3 25 | 1.30× | — | ||
| Q2 25 | 0.09× | 1.68× | ||
| Q1 25 | 2.53× | -0.75× | ||
| Q4 24 | 1.10× | 1.72× | ||
| Q3 24 | 1.14× | 2.61× | ||
| Q2 24 | -0.02× | 2.04× | ||
| Q1 24 | 1.35× | 0.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MO
| Smokeable Products Segment | $5.1B | 88% |
| Oral Tobacco Segment | $706.0M | 12% |
TAP
暂无分部数据